TerrAscend (TSNDF) Retained Earnings (2021 - 2026)

TerrAscend's (TSNDF) quarterly Retained Earnings came in at -$873.8 million in Q1 2026, down 10.32% year-on-year from -$974.3 million in Q1 2025, and down 191.0% on a QoQ basis from $960.2 million in Q4 2025.

TerrAscend (TSNDF) Retained Earnings (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Retained Earnings data on file, last reported at -$873.8 million in Q1 2026.

  • On a quarterly basis, Retained Earnings fell 10.32% year-over-year to -$873.8 million in Q1 2026; TTM through Mar 2026 was -$873.8 million, a 10.32% decrease from a year earlier, with the FY2025 full-year figure at $960.2 million, up 31791.1% from the prior year.
  • Retained Earnings for Q1 2026 stood at -$873.8 million, down from $960.2 million in the prior quarter.
  • Over the last five years, Retained Earnings for TSNDF reached as high as $960.2 million in Q4 2025 and fell as low as -$873.8 million in Q1 2026.
  • Historically, Retained Earnings has averaged $84.7 million across 5 years, with a median of $1.7 million in 2023.
  • On a YoY basis, Retained Earnings climbed as much as 54320.31% in 2024 and fell as far as 46476.71% in 2024.
  • Year by year, Retained Earnings stood at -$618.3 million in 2022, then surged by 252.83% to $944.9 million in 2023, then sank by 99.68% to $3.0 million in 2024, then jumped by 31791.1% to $960.2 million in 2025, then slumped by 191.0% to -$873.8 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$873.8 million in Q1 2026, $960.2 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn -873.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -873.80 Mn
Dec 31, 2025 960.24 Mn
Sep 30, 2025 2.17 Mn
Jun 30, 2025 -841.47 Mn
Mar 31, 2025 -792.09 Mn
Dec 31, 2024 3.01 Mn
Sep 30, 2024 -746.67 Mn
Jun 30, 2024 945.80 Mn
Mar 31, 2024 945.83 Mn
Dec 31, 2023 944.86 Mn
Sep 30, 2023 1.61 Mn
Jun 30, 2023 945.93 Mn
Mar 31, 2023 1.74 Mn
Dec 31, 2022 -618.26 Mn
Sep 30, 2022 877.30 Mn
Jun 30, 2022 -315.13 Mn
Mar 31, 2022 -783,000.00
Dec 31, 2021 535.42 Mn